Antimicrobial and Controlled Release Studies of a Novel Nystatin Conjugated Iron Oxide Nanocomposite

<table>MTT assays of a normal fibroblast (3T3) cell line after 72 hours of treatment with free nystatin, MNPs, CS-MNP, and Nyst-CS-MNP at different concentrations.</table>

BioMed Research International

fig13

Figure 13

Figure 13: Antimicrobial and Controlled Release Studies of a Novel Nystatin Conjugated Iron Oxide Nanocomposite 